42065-72-5

Usage

Uses

Used in Pharmaceutical Industry:
(3-Chloropropyl)sulfaMoyl Chloride is used as a key intermediate for the production of pharmaceuticals. It aids in the synthesis of various sulfonamides, which are important classes of compounds in medicinal chemistry.
Used in Agrochemical Industry:
(3-Chloropropyl)sulfaMoyl Chloride is used as a reagent in the production of agrochemicals. It helps in the synthesis of various compounds that are used in the development of pesticides and other agricultural chemicals.
Used in Functional Materials Industry:
(3-Chloropropyl)sulfaMoyl Chloride is used as a precursor in the synthesis of functional materials. It contributes to the development of materials with specific properties for various applications.
Used in Industrial Product Manufacturing:
(3-Chloropropyl)sulfaMoyl Chloride is used as an important intermediate in the manufacturing of a range of industrial products. It plays a crucial role in the production process of various chemicals and materials.
It is important to handle and use (3-Chloropropyl)sulfaMoyl Chloride with caution, as it is a highly reactive and toxic substance. Proper safety measures should be taken during its use to minimize any potential risks.

Upstream product

• 7791-25-5 sulfuryl dichloride 
• 6276-54-6 3-chloropropylamine hydrochloride 

Downstream Products

• 911789-74-7 C₁₃H₁₇ClN₂O₆S 
• 1354438-16-6 C₉H₁₂ClFN₂O₂S 
• 1354438-13-3 C₉H₁₂ClFN₂O₂S 
• 1354438-20-2 C₉H₁₀ClF₃N₂O₂S 
• 1354438-11-1 C₉H₁₃ClN₂O₂S 
• 1354438-18-8 C₉H₁₂ClFN₂O₂S 
• 1354438-24-6 C₉H₁₀Cl₄N₂O₂S 

Relevant academic research and scientific papers

SULFAMIDE DERIVATIVE HAVING AN ADAMANTYL GROUP AND ITS PHARMACEUTICALLY ACCEPTABLE SALT

Provided is a sulfamide derivative having an adamantyl group represented by the following Formula 1, or a pharmaceutically acceptable salt thereof. The sulfamide derivative suppresses the activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), and

Synthesis and biological evaluation of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors

A new series of cyclic sulfamide derivatives were synthesized and evaluated for their ability to inhibit 11β-HSD1. Among this series, 18e showed good in vitro activity toward human 11β-HSD1, selectivity against 11β-HSD2, microsomal stability, and pharmacokinetic and safety profiles (hERG, CYP, and acute toxicity). Additionally, 18e exhibited good in vivo efficacy in rat and monkey models.

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and in the claims. The invention also relates to the use thereof for treat

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.

INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The invention relates to the substituted 1,2-ethylenediamines of general formula (I), wherein the groups R1 to R13, A, B, L and i are defined as in the description and the claims. The invention also relates to the use thereof in the

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1 to R13, A, B, L, and i are defined as indicated in the description and the claims, as well as the use thereof for treating Alzheimer''s disease (AD)

3-AMINOSULFONYL SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to 3-Aminosulfonyl Substituted Indole Derivatives, compositions comprising at least one 3-Aminosulfonyl Substituted Indole Derivative, and methods of using the 3-Aminosulfonyl Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof

The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.